Show simple item record

dc.contributor.authorKozin, Elliott D.
dc.contributor.authorRemenschneider, Aaron K
dc.contributor.authorBlevins, Nikolas H.
dc.contributor.authorJan, Taha A.
dc.contributor.authorQuesnel, Alicia M.
dc.contributor.authorChari, Divya A.
dc.contributor.authorKesser, Bradley W.
dc.contributor.authorFranck, Kevin H.
dc.contributor.authorMarchioni, Daniele
dc.contributor.authorBarker, Frederick G. II
dc.contributor.authorCarter, Bob
dc.contributor.authorJackler, Robert K.
dc.contributor.authorWelling, D. Bradley
dc.contributor.authorLee, Daniel J.
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:45Z
dc.date.available2022-08-23T15:45:45Z
dc.date.issued2020-10-01
dc.date.submitted2020-06-11
dc.identifier.citation<p>Kozin ED, Remenschneider AK, Blevins NH, Jan TA, Quesnel AM, Chari DA, Kesser BW, Weinstein JE, Ahsan SF, Telischi FF, Adunka OF, Weber P, Knoll RM, Coelho DH, Anne S, Franck KH, Marchioni D, Barker FG 2nd, Carter BS, Lustig LR, Bojrab DI, Bhansali SA, Westerberg BD, Lundy L, Jackler RK, Roland JT Jr, Chandrasekhar SS, Antonelli PJ, Carey JP, Welling DB, Slattery WH 3rd, Lee DJ; members of the American Neurotology Society Council, members of the American Otological Society Council, and members of the American Academy of Otolaryngology – Head and Neck Surgery Hearing Committee and Implantable Hearing Devices Committee. American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic. Otol Neurotol. 2020 Oct;41(9):1163-1174. doi: 10.1097/MAO.0000000000002868. PMID: 32925832. <a href="https://doi.org/10.1097/mao.0000000000002868" target="_blank" title="View article on publisher's site">View article on publisher's site</a></p>
dc.identifier.doi10.1097/mao.0000000000002868
dc.identifier.pmid32925832
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27600
dc.description.abstractThis combined American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Surgery Foundation document aims to provide guidance during the coronavirus disease of 2019 (COVID-19) on 1) "priority" of care for otologic and neurotologic patients in the office and operating room, and 2) optimal utilization of personal protective equipment. Given the paucity of evidence to inform otologic and neurotologic best practices during COVID-19, the recommendations herein are based on relevant peer-reviewed articles, the Centers for Disease Control and Prevention COVID-19 guidelines, United States and international hospital policies, and expert opinion. The suggestions presented here are not meant to be definitive, and best practices will undoubtedly change with increasing knowledge and high-quality data related to COVID-19. Interpretation of this guidance document is dependent on local factors including prevalence of COVID-19 in the surgeons' local community. This is not intended to set a standard of care, and should not supersede the clinician's best judgement when managing specific clinical concerns and/or regional conditions.Access to otologic and neurotologic care during and after the COVID-19 pandemic is dependent upon adequate protection of physicians, audiologists, and ancillary support staff. Otolaryngologists and associated staff are at high risk for COVID-19 disease transmission based on close contact with mucosal surfaces of the upper aerodigestive tract during diagnostic evaluation and therapeutic procedures. While many otologic and neurotologic conditions are not imminently life threatening, they have a major impact on communication, daily functioning, and quality of life. In addition, progression of disease and delay in treatment can result in cranial nerve deficits, intracranial and life-threatening complications, and/or irreversible consequences. In this regard, many otologic and neurotologic conditions should rightfully be considered "urgent," and almost all require timely attention to permit optimal outcomes. It is reasonable to proceed with otologic and neurotologic clinic visits and operative cases based on input from expert opinion of otologic care providers, clinic/hospital administration, infection prevention and control specialists, and local and state public health leaders. Significant regional variations in COVID-19 prevalence exist; therefore, physicians working with local municipalities are best suited to make determinations on the appropriateness and timing of otologic and neurotologic care.
dc.language.isoen_US
dc.relation<p><a href="https://pubmed.ncbi.nlm.nih.gov/32925832/" target="_blank" title="View article in PubMed">Link to article in PubMed</a></p>
dc.rightsCopyright 2020, Otology and Neurotology, Inc. This is the accepted manuscript version posted after a 12-month embargo with a Creative Commons BY-NC license as allowed by the publisher's author rights policy at http://www.wkopenhealth.com/Institutions.html.
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCoronavirus
dc.subjectCOVID-19
dc.subjectotolaryngology
dc.subjectENT
dc.subjectotology
dc.subjectneurotology
dc.subjectmastoidectomy
dc.subjectcraniotomy
dc.subjectaerosolization
dc.subjectendoscopic ear surgery
dc.subjectexoscope
dc.subjectprotective personal equipment
dc.subjectPPE
dc.subjectFFP
dc.subjectPAPR
dc.subjectN95
dc.subjectHealth Services Administration
dc.subjectInfectious Disease
dc.subjectOtolaryngology
dc.subjectOtorhinolaryngologic Diseases
dc.subjectPatient Safety
dc.subjectVirus Diseases
dc.titleAmerican Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic
dc.typeAccepted Manuscript
dc.source.journaltitleOtology and Neurotology
dc.source.volume41
dc.source.issue9
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1052&amp;context=covid19&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/51
dc.legacy.embargo2021-10-01T00:00:00-07:00
dc.identifier.contextkey18061764
refterms.dateFOA2022-08-23T15:45:45Z
html.description.abstract<p>This combined American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Surgery Foundation document aims to provide guidance during the coronavirus disease of 2019 (COVID-19) on 1) "priority" of care for otologic and neurotologic patients in the office and operating room, and 2) optimal utilization of personal protective equipment. Given the paucity of evidence to inform otologic and neurotologic best practices during COVID-19, the recommendations herein are based on relevant peer-reviewed articles, the Centers for Disease Control and Prevention COVID-19 guidelines, United States and international hospital policies, and expert opinion. The suggestions presented here are not meant to be definitive, and best practices will undoubtedly change with increasing knowledge and high-quality data related to COVID-19. Interpretation of this guidance document is dependent on local factors including prevalence of COVID-19 in the surgeons' local community. This is not intended to set a standard of care, and should not supersede the clinician's best judgement when managing specific clinical concerns and/or regional conditions.Access to otologic and neurotologic care during and after the COVID-19 pandemic is dependent upon adequate protection of physicians, audiologists, and ancillary support staff. Otolaryngologists and associated staff are at high risk for COVID-19 disease transmission based on close contact with mucosal surfaces of the upper aerodigestive tract during diagnostic evaluation and therapeutic procedures. While many otologic and neurotologic conditions are not imminently life threatening, they have a major impact on communication, daily functioning, and quality of life. In addition, progression of disease and delay in treatment can result in cranial nerve deficits, intracranial and life-threatening complications, and/or irreversible consequences. In this regard, many otologic and neurotologic conditions should rightfully be considered "urgent," and almost all require timely attention to permit optimal outcomes. It is reasonable to proceed with otologic and neurotologic clinic visits and operative cases based on input from expert opinion of otologic care providers, clinic/hospital administration, infection prevention and control specialists, and local and state public health leaders. Significant regional variations in COVID-19 prevalence exist; therefore, physicians working with local municipalities are best suited to make determinations on the appropriateness and timing of otologic and neurotologic care.</p>
dc.identifier.submissionpathcovid19/51
dc.contributor.departmentDepartment of Otolaryngology
dc.source.pages1163-1174


Files in this item

Thumbnail
Name:
ANS_Position_Statement_COVID19 ...
Size:
6.588Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright 2020, Otology and Neurotology, Inc. This is the accepted manuscript version posted after a 12-month embargo with a Creative Commons BY-NC license as allowed by the publisher's author rights policy at http://www.wkopenhealth.com/Institutions.html.
Except where otherwise noted, this item's license is described as Copyright 2020, Otology and Neurotology, Inc. This is the accepted manuscript version posted after a 12-month embargo with a Creative Commons BY-NC license as allowed by the publisher's author rights policy at http://www.wkopenhealth.com/Institutions.html.